• Diana Caballero-Hernández Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, (México)
  • Reyes Tamez-Guerra Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, (México)
  • Cristina Rodríguez-Padilla Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, (México)
  • Patricia Tamez- Guerra Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, (México)
  • Richard J. Weber Department of Biomedical and Therapeutic Sciences, UIC College of Medicine, Peoria, IIL (USA)
  • Ricardo Gómez Flores Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, (México)


El diseño y síntesis de opioides no peptídicos con un perfil farmacológico especifico representa un prometedor campo de estudio, así como una fuente de nuevos compuestos con potencial aplicación terapéutica. En este trabajo hemos evaluado una serie de opioides sintéticos no peptídicos por sus propiedades inmunoreguladoras y antitumorales. Los resultados de este estudio apoyan la noción según la cual los opioides sintéticos, en la misma forma que los naturales, poseen propiedades bioreguladoras de importancia. Mas aun, las observaciones obtenidas con el
agonista opioide SNC 80, sugieren para este compuesto un gran potencial clínico como analgésico no inmunosupresor, y/o agente antitumoral.

Palabras clave: SNC80, antiproliferativo, inmunoestimulante, proinflamatorio   SNC80, antiproliferative, immunostimulating, pro-inflammatory


Los datos de descargas todavía no están disponibles.


Cargando métricas ...


Sharp, B.M., W.F. Keane, H.J. Suh, G. Gekker, D. Tsukayama and P.K. Peterson. 1985. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and

macrophages. Endocrinology Vol. 117: 793-795.

Shavit Y., G.W. Terman, F.A. Martin, J.W. Lewis, J.C. Liebeskind and R.P. Gale, R.P. 1985. Stress, opioid peptides, the immune system, and cancer. J. Immunol. Vol. 135: 2.

Weber, R.J. and A. Pert. 1989. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science Vol. 245: 188-190.

Roy, S. and H.H. Loh. 1996. Effects of opioids on the immune system. Neurochem. Res. Vol. 21: 1375.

Guan, L., R. Townsend, T.K. Eisenstein, M.W. Adler and T.J. Rogers. 1995. The cellular basis for opioid-induced immunosuppression. Adv. Exp. Med. Biol. Vol. 373: 57-64.

Tubaro, E., G. Borelli, C. Croce, G. Cavallo and C. Santiangeli. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. Vol. 148: 656-666.

Watson, R.R., R.H. Prabhala, H.R. Darban, M.D. Yahya and T.L. Smith. 1988. Changes in lymphocyte and macrophage subsets due to morphine and ethanol treatment during a retrovirus

infection causing murine AIDS. Life Sci Vol. 43: v-xi.

Yeager, M.P. and T.A. Colacchio. 1991. Effect of morphine on growth of metastatic colon cancer in vivo. Arch. Surg. Vol. 126: 454-456.

Hambrook, J.M., B.A. Morgan, M.J. Rance and C.F. Smith. 1976. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature. Vol. 262 No. 5571: 782-3.

Nowak, J.E., R. Gomez-Flores, S.N. Calderon, K.C. Rice and R.J. Weber 1998. Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80. J. Pharmacol. Exp. Ther. Vol. 286: 931-937.

Gomez-Flores, R., K.C. Rice, X. Zhang and R.J. Weber. 2001. Increased tumor necrosis factoralpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous

administration of the delta-opioid agonist SNC80. Life Sci. Vol. 68 No. 24: 2675-84.

Riley, M.E., S. Ananthan and R.J. Weber. 1998. Novel Non-peptidic opioid compounds with immunopotentiating effects. Adv. Exp. Med. Biol. Vol. 437: 183-187.

Gómez-Flores, R. and R.J. Weber. 1999. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine

administration: a role in natural killer and T cell supresion. J. Interferon Cytokine Res. Vol. 19: 625-30.

Gómez-Flores, R. and R.J. Weber. 2000. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon

periaqueductal gray Immunopharmacology Vol. 48 No. 2: 145-56.

Franco-Molina, M., R. Gomez-Flores, P. Tamez-Guerra, R. Tamez-Guerra, L. Castillo-Leon and C. Rodríguez-Padilla. 2003. In vitro Immunopotentiating Properties and Tumor Cell Toxicity Induced byLophophora williamsii (Peyote) Cactus Methanolic Extract. Phytother. Res. Vol. 17 No. 9: 1076- 81.

Gomez-Flores, R. et. al., Op.cit.

Gómez-Flores, R. and R.J. Weber. 2000, Op.cit.

Franco-Molina, M., et. al., Op.cit.


Carpenter, G.W., L. Breeden and D.J. Carr. 1995. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity. Int. J. Immunopharmacol. Vol. 17 No. 12: 1001-6.

Zagon, I.S. and P.J. McLaughlin. 2003. Opioids and the apoptotic pathway in human cancer cells.Neuropeptides Vol. 37 No. 2: 79-88.

Kawase, M., H. Sakagami, K. Furuya, H. Kikuchi, H. Nishikawa, N. Motohashi, Y. Morimoto, A. Varga and J. Molnar. 2002. Cell death-inducing activity of opiates in human oral tumor cell lines. Anticancer Res. Vol. 22 No. 1A: 211-4.

Bonn, D. 2002. Morphine stimulates tumour growth. Lancet Oncol. Vol. 3 No. 9: 520.

Kajdaniuk, D., B. Marek, B. Buntner and K. Zwirska-Korczala. 2000. Do enkephalins and other endogenous opioids participate in regulation of cancer growth?. Postepy. Hig. Med. Dosw. Vol. 54

No. 5: 597-608.

Dickenson, A.H. 1997. Plasticity: implication for opioid and other pharmacological interventions in specific pain states. Behav. Brain Sci. Vol. 20:392-403.

Nowak, J.E. et al., Op. cit.

Gómez-Flores, R. and R.J. Weber. 1999, Op. cit.

Gómez-Flores, R. and R.J. Weber. 2000, Op.cit.

McCarthy, L., M. Wetze, J.K. Sliker, T.K. Eisenstein and T.J. Rogers. 2001. Opioid, opioids receptors and the immune response. Drug Alcohol Depend. Vol. 62 No. 2: 111-123.

Carr, D.J., R.T. Radulescu, B.R. deCosta, K.C. Rice and J.E. Blalock. 1990. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer´s patches and spleen. Life Sci. Vol. 47 No. 12: 1059-69.

Dantzer, R. and K.W. Kelley. 1989. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. Vol. 1995: 2008

Maneckjee, R., R. Biswas and B.K. Vonderhaar. 1990. Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res. Vol. 50: 2234-2238

Maneckjee, R. and J.D. Minna. 1990. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. Vol. 87: 3294-3300.

Panagiotou, S., E. Bakogeorgou, E. Papakonstanti, A. Hatzoglou, F. Wallet, C. Dussert, C. Stournaras, P.M. Martin and E. 1999. Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements. J. Cell. Biochem. Vol. 73 No. 2: 204-11.

Calderon, S.N., R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, R.W. McNutt, H. Xu, L.E. Smith, E.J. Bilsky, P. Davis and K.C. Rice. 1994. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+) (+)-4-((alpha R)9-alpha-((2S, 5R)-4-allyl-2, 5-dimethyl-1- piperazinyl)-3-methoxybenzyl)-N, N-diethyl-benzamide (SNC80): A highly selective, nonpeptide d opioid receptor. J. Med. Chem. Vol. 37: 2125-2128.

Bilsky, E.J., S.N. Calderon T. Wang, R.N. Bernstein, P. Davis, V.J. Hruby, R.W. McNutt, R.B. Rothman, K. Rice and F. Porreca. 1995. SNC80, a selective, nonpeptidic and systemically active

opioid delta agonist. J. Pharmacol. Exp. Ther. Vol. 273: 359-66.

Negus, S.S., M.B. Gatch, N.K. Mello, X. Zhang and K. Rice. 1998. Behavioral effects of tha delta-selective opioid agonist SNC80 and related compounds in rhesus monkey. J. Pharm. Exp.

Ther. Vol. 286: 362-375.

Nowak, J.E. et al., Op. cit.

Gomez-Flores, R. et. al., Op.cit

Weber, R.J. and A. Pert, Op.cit.

Gómez-Flores, R. and R.J. Weber. 1999, Op. cit.

Gómez-Flores, R. and R.J. Weber. 2000, Op.cit.

Hohenwarter, O., K. Strutzenberger, H. Katinger, A. Liepins and J.W. Nowicky. 1992. Selective inhibition of in vitro cell growth by the anti-tumour drug ukrain. Drugs Exp. Clin. Res. Vol. 18: Suppl


Zhang, X.D, T. Nguyen, W.D. Thomas, J.E. Sanders and P. Hersey. 2000. Mechanisms of resistance of normal cells to TRAIL induced apptosis vary between different cell types. FEBS Lett.

Vol. 482: 193-199.

Durig J., N.G. Testa, B.I. Lord, C. Kasper, J. Chang, N. Telrford, T.M. Dexter and C.M. Heyworth. 1999. Characterization of the differential response of normal and CML haemopoietic

progenitor cells to macrophage inflammatory protein-1alpha. Leukemia Vol. 13: 2012-2022




Cómo citar

Caballero-Hernández, D., Tamez-Guerra, R., Rodríguez-Padilla, C., Tamez- Guerra, P., Weber, R. J., & Gómez Flores, R. (2004). OPIOIDES SINTÉTICOS NO PEPTÍDICOS CON PROPIEDADES INMUNOMODULADORAS Y ANTITUMORALES. RESPYN Revista Salud Pública Y Nutrición, 5(2). Recuperado a partir de https://respyn.uanl.mx/index.php/respyn/article/view/125



Artículo Original

Artículos más leídos del mismo autor/a